Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BioAtla

Explore full profile

Safer, more effective drugs for cancer using a proprietary next generation antibody discovery and evolution platform

San Diego, United StatesFounded 2007Biotech & Life Sciences
Valuation $3.5M Market cap · 2026
Revenue $2.0M Latest reported FY

About BioAtla

BioAtla, based in San Diego, is a pioneering biopharmaceutical company focused on creating innovative cancer treatments. The company specializes in developing monoclonal antibody and cell-based therapeutics through its proprietary Conditionally Active Biologics (CAB) platform. This technology leverages the unique microenvironment of diseased tissue to target cancer more effectively, thereby improving the therapeutic index and safety profile of its drugs. BioAtla serves the oncology market, primarily targeting patients with solid tumors. The company operates on a business model that includes research and development, clinical trials, and partnerships with other biotech firms and healthcare providers. Revenue is generated through licensing agreements, milestone payments, and eventual product sales.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2007
Headquarters
San Diego, United States
Listing
IPO 2020
Sector
Biotech & Life Sciences

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later15 investors entered at this stage

  • Soleus Capital
  • HBM Healthcare Investments
  • Farallon Capital Management
  • Pappas Capital
  • Pfizer Ventures
  • Cormorant Asset Management
  • Janus Henderson Investors
  • Boxer Capital
  • Hudson Bay Capital Management
  • Great Point Partners
  • Sphera Funds Management
  • Monashee Investment Management
  • EcoR1 Capital
  • Adage Capital
  • Yorkville Advisors

Talent

Book a demo to see the people
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BioAtla on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioAtla on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles